$LJPC LA JOLLA PHARMACEUTICAL CO Insider Trading Week 41/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO in week 41/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.25 | 22 | 358 | 22 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 16.25 | 22 | 358 | 22 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.81 | 22 | 304 | 522 | 500 to 522 (+4.40 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 13.81 | 22 | 304 | 522 | 500 to 522 (+4.40 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.25 | 15 | 244 | 15 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 16.25 | 15 | 244 | 15 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.81 | 15 | 207 | 2,100 | 2.1 K to 2.1 K (+0.72 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 13.81 | 15 | 207 | 2,100 | 2.1 K to 2.1 K (+0.72 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.25 | 55 | 894 | 55 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 16.25 | 55 | 894 | 55 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.81 | 55 | 760 | 74,383 | 74.3 K to 74.4 K (+0.07 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 13.81 | 55 | 760 | 74,383 | 74.3 K to 74.4 K (+0.07 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.25 | 88 | 1,430 | 88 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 16.25 | 88 | 1,430 | 88 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.81 | 88 | 1,215 | 1,280,774 | 1.3 M to 1.3 M (+0.01 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 13.81 | 88 | 1,215 | 1,280,774 | 1.3 M to 1.3 M (+0.01 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.25 | 85 | 1,381 | 85 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 16.25 | 85 | 1,381 | 85 | |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.81 | 85 | 1,174 | 6,585 | 6.5 K to 6.6 K (+1.31 %) |
| Oct 15 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 13.81 | 85 | 1,174 | 6,585 | 6.5 K to 6.6 K (+1.31 %) |